Lewis Seiden | Academic Influence

Lewis Seiden's AcademicInfluence.com Rankings

Lewis Seiden

Medical

#2462

World Rank

#2889

Historical Rank

#467

USA Rank

Pharmacology

#253

World Rank

#299

Historical Rank

#34

USA Rank

medical Degrees

Download Badge

Medical

Lewis Seiden's Degrees

PhD Pharmacology University of Chicago
Doctorate Medicine University of Chicago

Why Is Lewis Seiden Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Lewis Stanford Seiden was an American pharmacologist and professor at the University of Chicago. Early life and education Seiden was born in Chicago on August 1, 1934, where he grew up in the South Shore neighborhood. After graduating from high school, he received a full scholarship to the University of Chicago, where he had intended to study medicine. However, in 1950, when he was about to graduate from high school, he developed dystonia; he resumed studies at the University of Chicago the following year after recovering. He continued to struggle with dystonia for the rest of his life. He received his A.B. from the University of Chicago in 1956, where he also received his S.B. in 1958 and his Ph.D. in 1962. After receiving his Ph.D., he did postdoctoral research in the lab of Arvid Carlsson at the University of Goteborg in Sweden for two years , and then did another postdoc with Keith Killam from 1964 to 1965 at Stanford University.

(See a Problem?)

Lewis Seiden's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Amphetamine: effects on catecholamine systems and behavior. (1993) (847)
Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine (1980) (547)
A rapid method for the regional dissection of the rat brain (1980) (533)
Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study (1980) (506)
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain (1982) (491)
Determination of discount functions in rats with an adjusting-amount procedure. (1997) (465)
Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987) (446)
Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. (1985) (372)
Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat (1998) (359)
Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. (1976) (317)
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine (1984) (239)
Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers (1984) (234)
Feeding increases dopamine metabolism in the rat brain. (1980) (216)
Long-term effects of chronic methamphetamine administration in rhesus monkeys (1989) (205)
Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. (1996) (155)
Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain (1990) (154)
Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate (1980) (144)
Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons (1990) (143)
Neurotoxicity in Dopamine and 5‐Hydroxytryptamine Terminal Fields: A Regional Analysis in Nigrostriatal and Mesolimbic Projections (1988) (132)
Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat (1979) (128)
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. (1996) (125)
Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey (1992) (122)
Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. (1996) (116)
Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. (1979) (116)
Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. (2003) (116)
Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes (1983) (115)
Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs. (1983) (115)
Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine (1988) (111)
Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. (1995) (106)
DRL interresponse-time distributions: quantification by peak deviation analysis. (1993) (105)
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. (1997) (104)
Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. (1996) (103)
Psychopharmacology: A Biochemical and Behavioral Approach (1977) (96)
Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. (1995) (95)
Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion (1981) (94)
Evaluation of d‐amphetamine effects on the binding of dopamine D‐2 receptor radioligand, 18F‐fallypride in nonhuman primates using positron emission tomography (1997) (91)
Neurochemical similarities between d,l-cathinone and d-amphetamine. (1982) (91)
Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain (1985) (90)
α-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex (1986) (87)
Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. (1989) (86)
D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain (1989) (80)
Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine (1982) (80)
5,6-dihydroxytryptamine, a serotonergic neutotoxin, is formed endogenously in the rat brain (1987) (78)
Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice. (1968) (78)
α-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation (1990) (78)
Reserpine attenuates d-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis (1998) (77)
Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule (2005) (77)
Performance influence on the development of tolerance to amphetamine. (1973) (71)
EFFECT OF α-METHYLTYROSINE ON OPERANT BEHAVIOR AND BRAIN CATECHOLAMINE LEVELS (1969) (68)
Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine (1983) (65)
The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats. (1980) (65)
Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. (1988) (64)
Fluoxetine attenuates the dl-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis (1992) (63)
Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine (1987) (63)
Determination of dopamine norepinephrine, serotonin and their major metabolic products in rat brain by reverse-phase ion-pair high performance liquod chromatography with electrochemical detection (1985) (61)
Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. (1971) (61)
The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3,4-methylenedioxymethamphetamine and p-chloroamphetamine (1992) (59)
Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule. (1989) (57)
Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion (1984) (57)
The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat. (1976) (57)
A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. (1991) (56)
The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat (1990) (55)
Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats (1981) (54)
Catecholamines and drug-behavior interactions. (1975) (47)
Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram. (1968) (47)
Operant Behavior Changes Norepinephrine Metabolism in Rat Brain (1972) (46)
Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule. (1988) (45)
Differential effects of imipramine in rats as a function of DRL schedule value (1980) (45)
Behavioral screen for antidepressants: The effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule (2004) (43)
The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine (1980) (43)
The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat (1999) (43)
Synthesis of catecholamines from [3H]tyrosine in brain during the performance of operant behavior (1980) (41)
BIMT 17: a putative antidepressant with a fast onset of action? (1997) (41)
Regional effects of lateral hypothalamic lesions on brain norepinephrine in the cat. (1966) (41)
Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats (1989) (40)
Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys (1989) (38)
Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride (1981) (37)
Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs (1999) (36)
Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine (1982) (36)
Regional changes in brain catecholamine turnover in the rat during performance on fixed ratio and variable interval schedules of reinforcement (1981) (36)
Amphetamine analogs have differential effects on DRL 36-s schedule performance (1995) (36)
The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats. (1979) (36)
Neurochemical consequences following administration of CNS stimulants to the neonatal rat (1981) (35)
Temporary and partial antagonism by l-DOPA of reserpine-induced suppression of a conditioned avoidance response (1963) (35)
Sleep deprivation in the rat: XVIII. Regional brain levels of monoamines and their metabolites. (1994) (34)
Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate (2004) (33)
Fenfluramine: neurotoxicity. (1986) (32)
Behavioral and neurochemical evaluation of phenylpropanolamine. (1986) (32)
Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats (2005) (31)
Effects of diethyldithiocarbamate on the conditioned avoidance response of the rat (1968) (31)
Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia. (1998) (30)
Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles (1997) (29)
The effects of p-chloroamphetamine administration on locomotor activity and serotonin in neonatal and adult rats. (1981) (28)
Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats (1990) (28)
Behavioral consequences of partial monoamine depletion in the CNS after methamphetamine-like drugs: the conflict between pharmacology and toxicology. (1993) (27)
The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine’s antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats (2000) (27)
5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. (1973) (27)
Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds (1998) (27)
Methylphenidate and d-amphetamine: Effects and interactions with alphamethyltyrosine and tetrabenazine on DRL performance in rats (1979) (26)
Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine (1983) (26)
Methamphetamine‐induced Neurotoxicity: Structure Activity Relationships (1992) (25)
A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task (1993) (25)
Sensitivity changes to dopaminergic agents in fine moto control of rhesus monkeys after repeated methamphetamine administration (1985) (23)
Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance. (1993) (23)
alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. (1986) (23)
Role of lever responding and water presentation in altering rat brain catecholamine metabolism. (1978) (23)
Chlorpromazine and pimozide alter reinforcement efficacy and motor performance (2004) (23)
Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons. (1983) (22)
Effects of serotonergic antagonists and antagonists on the locomotor activity of neonatal rats (1986) (22)
Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase. (1971) (21)
A selective effect of p-chlorophenylalanine on fixed-ratio responding. (1971) (21)
Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. (1990) (20)
The role of catecholamines in the action of drugs affecting behavior. (1976) (20)
Brain and heart catecholamine levels after l-Dopa administration in reserpine treated mice: Correlations with a conditioned avoidance response (1964) (20)
Increased transport of 3,4-dihydroxyphenylacetic acid from brain during performance of operant behavior in the rat (1984) (20)
A parametric description of amphetamine's effect on response rate: changes in reinforcement efficacy and response topography (2004) (20)
Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields (1997) (19)
Increased hypothalamic norepinephrine metabolism after water deprivation in the rat (1981) (19)
Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine (2004) (18)
Behavioral and neuroendocrine responses to light mediated by separate visual pathways in the rat (1969) (18)
Effects of intermittent and repeated administration of d-amphetamine on restricted water intake in rats. (1976) (17)
The effects of methamphetamine on fine motor control in rhesus monkeys (1979) (17)
Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by l-DOPA (1964) (17)
Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats (1992) (17)
Time-dependent changes in hypothalamic dopamine metabolism during feeding in the rat (1984) (17)
Changes in Brain Catecholamines Induced by Long-Term Methamphetamine Administration in Rhesus Monkeys (1977) (17)
Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine. (1984) (17)
Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule (1997) (17)
α-Methyl-p-tyrosine partially attenuates p-chloroamphetamine-induced 5-hydroxytryptamine depletions in the rat brain (1990) (16)
Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior (2004) (16)
Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions (2005) (16)
Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine (1988) (16)
Methamphetamine: toxicity to dopaminergic neurons. (1985) (15)
Partial purification of monoamine oxidase from rat brain. (1962) (15)
Methamphetamine, physostigmine, atropine and mecamylamine: Effects on force lever performance (1985) (14)
Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response. (1969) (13)
Ambient Temperature Influences Core Body Temperature Response in Rat Lines Bred for Differences in Sensitivity to 8-Hydroxy-dipropylaminotetralin (2003) (13)
Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity (2005) (13)
d-Amphetamine-induced increase in catecholamine synthesis in the corpus striatum of the rat: Persistence of the effect after tolerance (2005) (13)
Effects of schedules of reinforcement on brain catecholamine metabolism in the rat (1977) (12)
Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life (2004) (11)
Interresponse time changes as a function of water deprivation and amphetamine. (1975) (11)
The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses ofdl-fenfluramine (1992) (10)
Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam (1994) (10)
The effect of relative and absolute reinforcement magnitude on operant responding. (1974) (10)
α‐Methyltyrosine: effects on fixed ratio schedules of reinforcement (1967) (9)
DRL performance in 6-hydroxydopamine-treated rats (1980) (9)
Behavioral and neurochemical effects of repeated or continuous exposure to cocaine. (1988) (9)
Neurotoxicity of methamphetamine and methylenedioxymethamphetamine (2009) (9)
Time course for the effects of cocaine on fixed-ratio water-reinforced responding in rats (1975) (9)
Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior (1980) (8)
Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen. (1988) (8)
Water deprivation increases anterior hypothalamic norepinephrine metabolism in the rat (1985) (8)
Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement (1993) (8)
Rats selectively bred for responsiveness to 5-hydroxytryptamine(1A) receptor stimulation: differences in differential reinforcement of low rate 72-second performance and response to serotonergic drugs. (2000) (8)
Hypothalamic catecholamine metabolism is increased by acute water imbalance (1986) (7)
A system for the recording and analysis of interresponse-time data using an AM tape recorder and digital computers. (1969) (7)
Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum (1991) (7)
The ontogeny of aggregation-enhanced toxicity (1981) (7)
Effects of salbutamol upon performance on an operant screen for antidepressants (2005) (6)
Methamphetamine and related drugs: toxicity and resulting behavioral changes in response to pharmacological probes. (1989) (6)
Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity (2004) (6)
Locomotor hyperactivity following chronic alpha-methyltyrosine administration in the neonatal rat. (1982) (5)
The effect of water-deprivation on locomotor activity in rats treated with 6-hydroxydopamine (1985) (5)
ISI Atlas of Science: Pharmacology 1987, Vol. 1. (1989) (5)
Effect of the experimental antidepressant AHR-9377 on performance during differential reinforcement of low response rate (2004) (4)
Brain monoamines and behavior. (1975) (4)
MECHANISM OF IPRONIAZID INHIBITION OF BRAIN MONOAMINE OXIDASE. (1963) (3)
Catecholamines, drugs, and behavior: mutual interactions. (1974) (3)
Lack of toxic effects of cocaine on dopamine or serotonin neurons in the rat brain. (1988) (3)
Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels. (1969) (3)
Repeated Injection of Cocaine Potentiates Methamphetamine‐induced Toxicity to Dopamine‐containing Neurons in Rat Striatum (1992) (2)
Transporters of delight (1992) (2)
Effects of methamphetamine on atropine-induced conditioned gustatory avoidance (1984) (2)
Methamphetamine: Toxicity to dopaminergic neurons.: (473072004-001) (1985) (2)
5 – The Ontogeny of Locomotor Behavior following Lesions of Brain Dopamine Neuronal Projections in the Neonatal Rat (1984) (2)
Behavioral pharmacology : the current status : proceedings of the joint meeting between the Behavioral Pharmacology Division of the American Psychological Association and the American Association for Pharmacology and Experimental Therapeutics, held in St. Louis, Missouri, April 2-6, 1984 (1985) (2)
MDMA and Related Compounds: Session Summary (1990) (2)
Behavioral Methods in Pharmacology (1973) (1)
Effects of embryonic and neonatal disruption of developing central dopaminergic systems. (1979) (1)
AGE-DEPENDENT EFFECTS OF 6-HYDROXYDOPAMINE ON LOCOMOTOR ACTIVITY IN RATS (1979) (1)
The effect of repeated desipramine administration on water intake in rats (2004) (1)
The interaction of injected reserpine and dihydroxyphenylalanine or D-amphetamine on electrophysiological and behavioral responses in a conditioned approach situation in the cat. (1966) (0)
Development of monoaminergic systems in the mouse is largely unaffected by knock-down of GABAA receptors (1999) (0)
MK-801 GIVEN IN COMBINATION WITH SUBSTITUTED PHENETHYLAMINES DECREASES CORE BODY TEMPERATURE IN RATS (1992) (0)
BEHAVIORAL MECHANISM OF THE EFFECTS OF DESIPRAMINE ON THE DRL 72-S ANTIDEPRESSANT SCREEN (1992) (0)
Interactions of neurotransmitters with drugs and behavior. (1992) (0)
MK801 ENHANCES THE SEROTONIN DEPLETIONS INDUCED BY FENFLURAMINE (1992) (0)
The effects of intracerebroventricular administration of 5,6-dihydroxytryptamine to neonatal rats (1982) (0)
A behavioral tool for screening antidepressant drugs and neurochemical mechanisms (1994) (0)
Periodic high-dose methamphetamine causes DRL 36-S acquisition deficits in rats (1994) (0)
Psychopharmacology. A biochemical and behavioral approach Seiden, L.S. and L.A. Dykstra. New York: Van Nostrand Reinhold Co., 1977, 451 pp., $19.95 (1977) (0)
LACK OF EVIDENCE FOR A ROLE OF DOPAMINE IN THE LONG-TERM DEPLETIONS OF SEROTONIN CAUSED BY FENFLURAMINE (1992) (0)
Neurotransmitters in Affective Disorders (2013) (0)
Toxicity of Amphetamine-Related Drugs and Resulting Behavioral Changes (1990) (0)
Psychiatry and the Biology of the Human Brain: A Symposium Dedicated to Seymour S. Kety (Proceedings of the October 12-13, 1979 Conference on Psychiatry and the Biology of the Human Brain, McLean Hospital, Belmont, Massachusetts) (1982) (0)
THE DRL ANTIDEPRESSANT SCREEN (1992) (0)
Book Review:Psychopharmacology. Alan A. Boulton, Glen B. Baker, Andrew J. Greenshaw (1990) (0)

This paper list is powered by the following services:

Other Resources About Lewis Seiden

en.wikipedia.org

What Schools Are Affiliated With Lewis Seiden?

Lewis Seiden is affiliated with the following schools:

University of Chicago